HTG Molecular Diagnostics Inc (HTGMQ)
0.0025
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
HTG Molecular Diagnostics Cash from Operations (TTM): -16.83M for March 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -16.83M |
| December 31, 2022 | -18.41M |
| September 30, 2022 | -19.77M |
| June 30, 2022 | -19.40M |
| March 31, 2022 | -18.09M |
| December 31, 2021 | -16.51M |
| September 30, 2021 | -16.67M |
| June 30, 2021 | -16.81M |
| March 31, 2021 | -16.72M |
| December 31, 2020 | -16.29M |
| September 30, 2020 | -16.60M |
| June 30, 2020 | -16.31M |
| March 31, 2020 | -15.03M |
| December 31, 2019 | -16.70M |
| September 30, 2019 | -15.41M |
| June 30, 2019 | -14.93M |
| March 31, 2019 | -16.07M |
| Date | Value |
|---|---|
| December 31, 2018 | -13.17M |
| September 30, 2018 | -13.42M |
| June 30, 2018 | -13.99M |
| March 31, 2018 | -14.64M |
| December 31, 2017 | -16.57M |
| September 30, 2017 | -18.67M |
| June 30, 2017 | -18.90M |
| March 31, 2017 | -20.75M |
| December 31, 2016 | -22.23M |
| September 30, 2016 | -21.87M |
| June 30, 2016 | -21.98M |
| March 31, 2016 | -20.95M |
| December 31, 2015 | -19.24M |
| September 30, 2015 | -17.46M |
| June 30, 2015 | -16.55M |
| March 31, 2015 | -13.63M |
| December 31, 2014 | -13.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-19.77M
Minimum
Sep 2022
-14.93M
Maximum
Jun 2019
-16.91M
Average
-16.68M
Median
Cash from Operations (TTM) Benchmarks
| Viveve Medical Inc | -16.23M |
| Minerva Surgical Inc | -38.73M |
| Stereotaxis Inc | -9.139M |
| Electromed Inc | 4.872M |
| Myomo Inc | -6.173M |